Unibest
← Back to patent-cliff list

CAS 592-34-7

butyl carbonochloridate

Codes: M-024-008, ACT-246475-009

Application context (from source-drug indications)

COVID-19BuloxibutidIdiopathic pulmonary fibrosisBuloxibutid雷诺氏病BuloxibutidSystemic sclerosisBuloxibutidMyocardial infarctionSelatogrel慢性冠脉综合征SelatogrelHepatic function declineSelatogrelCoronary artery lesionSelatogrel

Source drugs (routes using this intermediate)

DrugTierExpiry
BuloxibutidTier C — Watch / trade-
SelatogrelTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.